Firefly Neuroscience (AIFF) Financials

Firefly Neuroscience’s latest results show strong top-line growth but continued heavy operating losses. Revenue reached $514,000 in Q2 2026, up 6.0% from $485,000 in Q1 and 72% from $299,000 in Q2 2025. Revenue has generally increased from the very low levels reported in 2023 and 2024, although the company remains in an early commercialization stage.

Gross profit was $253,000 in Q2, producing a gross margin of approximately 49.2%. This improved from 45.6% in Q1 2026 but was well below the 91.6% margin reported in Q2 2025, when cost of revenue was unusually low. The recent increase in cost of revenue suggests that revenue growth has not yet translated into consistently strong unit economics.

Operating expenses remain substantially larger than gross profit. Q2 operating expenses totaled $2.227 million, including $1.522 million of selling, general and administrative expense, $525,000 of research and development expense, and $180,000 of marketing expense. R&D spending increased 56% from Q2 2025, while total operating expenses were broadly stable year over year. The company reported an operating loss of $1.974 million and a net loss of $1.984 million.

Losses have improved from the exceptionally weak results in early 2025 and late 2024, when quarterly net losses ranged from approximately $2.48 million to $13.0 million. However, Firefly has not yet demonstrated a path to profitability. Operating losses have remained close to $2 million in each of the first two quarters of 2026, despite the improvement in revenue.

Cash flow remains a major concern. Firefly used $1.75 million in operating cash during Q2 2026, following $1.948 million of operating cash outflow in Q1 and $1.805 million in Q4 2025. Capital expenditures were modest at $42,000 in Q2, so the cash burn is primarily related to ongoing operating losses rather than investment in property and equipment.

The balance sheet improved sharply during the quarter because of financing activity. Cash and equivalents rose from $3.127 million at March 31, 2026, to $9.226 million at June 30, while financing activities provided $7.891 million. Based on the Q2 operating cash burn, the cash balance represents roughly five quarters of operating runway before considering future changes in spending, revenue, working capital, or additional financing. The financing inflow, however, appears to be a key reason for the improved liquidity rather than internally generated cash.

Liquidity metrics are currently favorable. Current assets were $10.225 million versus current liabilities of $2.098 million, implying a current ratio of approximately 4.9. Total liabilities declined from $2.468 million in Q1 to $2.105 million in Q2. At the same time, retained earnings were negative $115.6 million, reflecting the company’s substantial accumulated losses.

• Revenue momentum is improving: Q2 2026 revenue increased 72% year over year and 6% sequentially, continuing the longer-term rise from the minimal revenue levels reported in 2023 and 2024.
• Gross profit increased sequentially: Gross profit rose from $221,000 in Q1 to $253,000 in Q2, while gross margin improved to approximately 49.2% from 45.6%.
• Liquidity strengthened materially: Cash increased to $9.226 million at quarter-end, and the current ratio was approximately 4.9, giving the company more flexibility to fund operations.
• Liabilities remain relatively low: Total liabilities of $2.105 million were substantially below total assets of $16.768 million, and short-term debt was limited to $478,000.
• Quarterly losses are lower than the 2024 and early-2025 extremes: The Q2 2026 net loss of $1.984 million was below the $2.48 million loss in Q4 2025 and far below the $13.0 million loss reported in Q1 2025.
• Financing provided most of the quarter’s cash increase: Financing activities generated $7.891 million, more than offsetting operating and investing cash outflows. This supports near-term liquidity but does not represent internally generated cash.
• R&D spending is rising: Research and development expense increased to $525,000 in Q2, which could support future product development but adds pressure to near-term earnings and cash flow.
• Firefly remains deeply unprofitable: The company posted a $1.974 million operating loss and a $1.984 million net loss in Q2, with operating expenses approximately 8.8 times gross profit.
• Operating cash burn persists: The company used $1.75 million in operating cash during Q2 and has reported negative operating cash flow in each of the recent quarters provided.
• Financing and dilution risk remain important: Common stock increased to $130.2 million from $122.1 million in Q1, while the reported share counts vary considerably across periods. Continued funding needs could require additional equity issuance and dilute existing shareholders.

Overall, Firefly’s financial profile is improving on revenue and near-term liquidity, but the investment case remains dependent on whether growth can accelerate enough to absorb its sizable fixed operating cost base. Investors should focus on sustained revenue growth, gross-margin consistency, operating cash burn, and the terms of future financing.